ArticleMolecular & cellular proteomics : MCP2015

Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study.

Marie Duhamel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.